268 related articles for article (PubMed ID: 12586031)
1. [Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Alvarez-Lerma F; Nolla J; Palomar M; León MA
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):83-8. PubMed ID: 12586031
[TBL] [Abstract][Full Text] [Related]
2. [Indications for antifungal treatment in intensive care unit patients].
Alvarez-Lerma F; Palomar M; León C; Olaechea P; Cerdá E; Bermejo B;
Enferm Infecc Microbiol Clin; 2004 May; 22(5):279-85. PubMed ID: 15207119
[TBL] [Abstract][Full Text] [Related]
3. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM
Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636
[TBL] [Abstract][Full Text] [Related]
4. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients.
Ferrer R; Zaragoza R; Llinares P; Maseda E; Rodríguez A; Quindós G;
Med Intensiva; 2017; 41(1):3-11. PubMed ID: 27645566
[TBL] [Abstract][Full Text] [Related]
5. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
6. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
7. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Nassoura Z; Ivatury RR; Simon RJ; Jabbour N; Stahl WM
J Trauma; 1993 Aug; 35(2):290-4; discussion 294-5. PubMed ID: 8355311
[TBL] [Abstract][Full Text] [Related]
8. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
[TBL] [Abstract][Full Text] [Related]
9. [Fungal infections in intensive care units: a cross-survey].
Dupont H
Ann Fr Anesth Reanim; 2001 Apr; 20(4):413-7. PubMed ID: 11392255
[TBL] [Abstract][Full Text] [Related]
10. EPICO 2.0 PROJECT. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodríguez A;
Rev Esp Quimioter; 2014 Sep; 27(3):196-212. PubMed ID: 25229375
[TBL] [Abstract][Full Text] [Related]
11. Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan.
Aikawa N; Sumiyama Y; Kusachi S; Hirasawa H; Oda S; Yamazaki Y
J Infect Chemother; 2002 Sep; 8(3):237-41. PubMed ID: 12373487
[TBL] [Abstract][Full Text] [Related]
12. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
13. [Role of anidulafungin in critically ill patients].
Borges Sá M; Garnacho Montero J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():35-43. PubMed ID: 19572433
[TBL] [Abstract][Full Text] [Related]
14. Bladder irrigation with amphotericin B and fungal urinary tract infection--systematic review with meta-analysis.
Tuon FF; Amato VS; Penteado Filho SR
Int J Infect Dis; 2009 Nov; 13(6):701-6. PubMed ID: 19155184
[TBL] [Abstract][Full Text] [Related]
15. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
[TBL] [Abstract][Full Text] [Related]
16. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
17. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
18. Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.
Keane S; Geoghegan P; Povoa P; Nseir S; Rodriguez A; Martin-Loeches I
Expert Rev Anti Infect Ther; 2018 Nov; 16(11):839-847. PubMed ID: 30257597
[TBL] [Abstract][Full Text] [Related]
19. [Candida peritonitis in a haemodynamically stable patient. First choice of antifungal treatment … fluconazole?].
Maseda E; Gilsanz F
Rev Iberoam Micol; 2012; 29(2):81-4. PubMed ID: 22463782
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of fungal urinary tract infection.
Kauffman CA
Infect Dis Clin North Am; 2014 Mar; 28(1):61-74. PubMed ID: 24484575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
